Variant report

Variant	nsv5538
Chromosome Location	chr6:150640370-150652751
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:150644374-150644606	K562	blood:	n/a	n/a
2	ARID3A	chr6:150648358-150648558	K562	blood:	n/a	n/a
3	ARID3A	chr6:150641709-150642002	K562	blood:	n/a	n/a
4	BHLHE40	chr6:150648590-150648641	K562	blood:	n/a	n/a
5	BHLHE40	chr6:150641556-150641951	K562	blood:	n/a	n/a
6	BHLHE40	chr6:150644360-150644691	K562	blood:	n/a	n/a
7	CCNT2	chr6:150641678-150642002	K562	blood:	n/a	n/a
8	CCNT2	chr6:150644328-150644856	K562	blood:	n/a	n/a
9	CEBPB	chr6:150643604-150643721	H1-hESC	embryonic stem cell:	n/a	n/a
10	CEBPB	chr6:150644223-150644687	K562	blood:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
11	CEBPB	chr6:150644348-150644705	A549	lung:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
12	CEBPB	chr6:150644288-150644668	IMR90	lung:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
13	CEBPB	chr6:150644321-150644649	HepG2	liver:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
14	CEBPB	chr6:150643567-150643852	K562	blood:	n/a	chr6:150643730-150643739 chr6:150643729-150643740 chr6:150643728-150643741
15	CEBPB	chr6:150644307-150644671	Hela-S3	cervix:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
16	CEBPB	chr6:150644290-150644662	A549	lung:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
17	CEBPB	chr6:150643557-150643916	HepG2	liver:	n/a	chr6:150643730-150643739 chr6:150643729-150643740 chr6:150643728-150643741
18	CEBPB	chr6:150644380-150644520	HepG2	liver:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
19	CEBPB	chr6:150644183-150644674	A549	lung:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
20	CEBPB	chr6:150644135-150644819	MCF-7	breast:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
21	CEBPB	chr6:150643545-150643910	K562	blood:	n/a	chr6:150643730-150643739 chr6:150643729-150643740 chr6:150643728-150643741
22	CEBPB	chr6:150646083-150646753	ECC-1	luminal epithelium:	n/a	chr6:150646173-150646185
23	CEBPB	chr6:150644140-150644809	HCT-116	colon:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
24	CEBPB	chr6:150644337-150644550	HepG2	liver:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
25	CEBPB	chr6:150644193-150644767	K562	blood:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
26	CEBPB	chr6:150644243-150644698	ECC-1	luminal epithelium:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
27	CEBPB	chr6:150644288-150644667	HepG2	liver:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
28	CEBPB	chr6:150644310-150644748	MCF-7	breast:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
29	CEBPB	chr6:150643562-150643891	MCF-7	breast:	n/a	chr6:150643730-150643739 chr6:150643729-150643740 chr6:150643728-150643741
30	CEBPB	chr6:150644234-150644757	K562	blood:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
31	CEBPB	chr6:150644273-150644665	H1-hESC	embryonic stem cell:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
32	CEBPB	chr6:150644185-150644801	ECC-1	luminal epithelium:	n/a	chr6:150644471-150644480 chr6:150644471-150644480 chr6:150644469-150644482 chr6:150644469-150644480 chr6:150644471-150644480 chr6:150644471-150644480
33	CEBPD	chr6:150644335-150644738	K562	blood:	n/a	chr6:150644471-150644480 chr6:150644469-150644480
34	CEBPD	chr6:150644232-150644737	K562	blood:	n/a	chr6:150644471-150644480 chr6:150644469-150644480
35	CEBPD	chr6:150644359-150644546	HepG2	liver:	n/a	chr6:150644471-150644480 chr6:150644469-150644480
36	CHD2	chr6:150647949-150648274	K562	blood:	n/a	n/a
37	CTCF	chr6:150641779-150642015	K562	blood:	n/a	n/a
38	CTCF	chr6:150641838-150641887	LNCaP	prostate:	n/a	n/a
39	CTCF	chr6:150641700-150641850	HPAF	blood vessel:	n/a	n/a
40	CTCF	chr6:150641806-150641939	K562	blood:	n/a	n/a
41	CTCF	chr6:150641812-150641850	HepG2	liver:	n/a	n/a
42	CTCF	chr6:150641760-150641910	K562	blood:	n/a	n/a
43	CTCF	chr6:150641960-150642110	HCM	heart:	n/a	n/a
44	CTCF	chr6:150641840-150641937	LNCaP	prostate:	n/a	n/a
45	CUX1	chr6:150643250-150643280	K562	blood:	n/a	n/a
46	CUX1	chr6:150644179-150644518	K562	blood:	n/a	n/a
47	CUX1	chr6:150641953-150642045	K562	blood:	n/a	n/a
48	E2F4	chr6:150646461-150646593	MCF10A-Er-Src	breast:	n/a	n/a
49	E2F6	chr6:150641645-150641849	K562	blood:	n/a	n/a
50	EBF1	chr6:150645966-150646161	GM12878	blood:	n/a	chr6:150646075-150646086 chr6:150646074-150646087 chr6:150645998-150646007 chr6:150645997-150646007

No.	Distal block	Cell Line	Cell type
1	chr6:150500428..150502661-chr6:150644242..150645820,2	K562	blood:
2	chr6:150637450..150641855-chr6:150642003..150645154,6	K562	blood:
3	chr6:150642390..150644728-chr6:150645013..150646951,2	K562	blood:
4	chr6:150586437..150588677-chr6:150642579..150644863,2	K562	blood:
5	chr6:150646137..150648585-chr6:150648675..150650937,2	MCF-7	breast:
6	chr6:150638163..150639671-chr6:150643884..150646332,2	MCF-7	breast:
7	chr6:150637450..150641855-chr6:150642003..150645154,6	K562	blood:
8	chr6:150630670..150634449-chr6:150639443..150643580,5	K562	blood:
9	chr6:150400447..150403376-chr6:150651283..150654200,2	K562	blood:
10	chr6:150642390..150644728-chr6:150645013..150646951,2	K562	blood:
11	chr6:150601201..150603369-chr6:150639907..150641803,2	MCF-7	breast:
12	chr6:150624607..150626485-chr6:150639529..150642176,2	K562	blood:
13	chr6:150514785..150516493-chr6:150643803..150645499,2	K562	blood:
14	chr6:150644840..150646705-chr6:150652961..150654511,2	K562	blood:
15	chr6:150642041..150644950-chr6:150645013..150647968,3	K562	blood:
16	chr12:120729257..120730114-chr6:150647863..150648380,2	Hela-S3	cervix:
17	chr6:150652538..150654492-chr6:150655790..150657493,2	K562	blood:

Variant related genes	Relation type
RNU4-7P	TF binding region
ENSG00000202538	chromatin interactions
ENSG00000201628	chromatin interactions

Extended variants
information (count: 501 )
Associated
traits (count: 83 )

Variant overlapped rSNPs/rCNVs (count:501 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs62441216	chr6:150640396-150640397	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs565721908	chr6:150640450-150640451	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs538675014	chr6:150640451-150640452	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs548612771	chr6:150640454-150640455	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs562446604	chr6:150640464-150640465	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs531106350	chr6:150640530-150640531	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs79301374	chr6:150640597-150640598	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs369597203	chr6:150640608-150640609	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs191487393	chr6:150640625-150640626	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs546689453	chr6:150640731-150640732	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs558652959	chr6:150640755-150640756	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs117497064	chr6:150640757-150640758	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs535387015	chr6:150640770-150640771	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs77730489	chr6:150640806-150640807	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs115516455	chr6:150640859-150640860	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs199737319	chr6:150640900-150640901	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs182643292	chr6:150640918-150640919	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs187983072	chr6:150640945-150640946	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs577391698	chr6:150641004-150641005	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs145280554	chr6:150641115-150641116	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs192999693	chr6:150641155-150641156	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs141876224	chr6:150641194-150641195	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs184702573	chr6:150641196-150641197	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs542253392	chr6:150641235-150641236	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs561911281	chr6:150641270-150641271	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs531266961	chr6:150641280-150641281	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs6914357	chr6:150641292-150641293	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs564691219	chr6:150641325-150641326	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs76614302	chr6:150641370-150641371	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs546726066	chr6:150641372-150641373	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs371599901	chr6:150641389-150641390	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs13199578	chr6:150641394-150641395	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs566611016	chr6:150641420-150641421	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs528960939	chr6:150641423-150641424	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs190366047	chr6:150641472-150641473	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs568725768	chr6:150641575-150641576	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs538164062	chr6:150641601-150641602	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs73614100	chr6:150641602-150641603	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs571121188	chr6:150641688-150641689	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs574590228	chr6:150641712-150641713	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs137922150	chr6:150641717-150641718	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs573313767	chr6:150641723-150641724	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs1538484	chr6:150641725-150641726	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs555745180	chr6:150641777-150641778	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs386707030	chr6:150641803-150641804	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs6919505	chr6:150641805-150641806	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs564728213	chr6:150641816-150641817	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs142473840	chr6:150641863-150641864	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs1538483	chr6:150641880-150641881	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs192011259	chr6:150641881-150641882	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:83)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Autism	22495311	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Follicular lymphoma	20505157	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
Renal cell carcinoma	18592004	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Malignant melanoma	17260012	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Soft tissue tumor	16732325	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
Cancer	17160897	CNVD
Breast cancer	17417639	CNVD
Breast cancer	17850661	CNVD
Renal cell carcinoma	18765545	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Breast cancer	21804112	CNVD
Myelofibrosis	22110671	CNVD
Ovarian neoplasms	16753589	CNVD
Retinoblastoma	22278416	CNVD
Breast cancer	20556506	CNVD
Hirschsprung''s Disease	21712996	CNVD
Testicular germ cell tumor	18059402	CNVD
Pancreatic cancer	17952125	CNVD
Developmental delay	21147756	CNVD

Chromatin state (count:148 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:150619600-150641200	Weak transcription	Right Atrium	heart
2	chr6:150635800-150641200	Weak transcription	Fetal Lung	lung
3	chr6:150636400-150640600	Weak transcription	Skeletal Muscle Male	skeletal muscle
4	chr6:150636400-150640800	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
5	chr6:150636600-150641000	Weak transcription	Right Ventricle	heart
6	chr6:150638000-150642200	Enhancers	Fetal Muscle Leg	muscle
7	chr6:150638200-150641200	Weak transcription	Fetal Heart	heart
8	chr6:150638400-150641200	Weak transcription	Left Ventricle	heart
9	chr6:150639000-150641000	Enhancers	Skeletal Muscle Female	skeletal muscle
10	chr6:150639600-150643200	Weak transcription	Lung	lung
11	chr6:150639800-150641000	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
12	chr6:150639800-150641000	Weak transcription	Psoas Muscle	Psoas
13	chr6:150640000-150641200	Weak transcription	K562	blood
14	chr6:150640400-150641200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
15	chr6:150640600-150643400	Enhancers	Skeletal Muscle Male	skeletal muscle
16	chr6:150640800-150641000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
17	chr6:150641000-150641400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
18	chr6:150641000-150641400	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
19	chr6:150641000-150641800	Enhancers	Fetal Muscle Trunk	muscle
20	chr6:150641000-150642000	Enhancers	Right Ventricle	heart
21	chr6:150641000-150642200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
22	chr6:150641000-150642200	Enhancers	Psoas Muscle	Psoas
23	chr6:150641200-150641400	Enhancers	Spleen	Spleen
24	chr6:150641200-150641600	Bivalent Enhancer	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
25	chr6:150641200-150641800	Enhancers	Left Ventricle	heart
26	chr6:150641200-150641800	Enhancers	Right Atrium	heart
27	chr6:150641200-150641800	Bivalent Enhancer	Stomach Mucosa	stomach
28	chr6:150641200-150642000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
29	chr6:150641200-150642000	Enhancers	Breast Myoepithelial Primary Cells	Breast
30	chr6:150641200-150642000	Enhancers	Aorta	Aorta
31	chr6:150641200-150642000	Enhancers	Fetal Heart	heart
32	chr6:150641200-150642000	Enhancers	Fetal Lung	lung
33	chr6:150641200-150645000	Enhancers	K562	blood
34	chr6:150641400-150642000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
35	chr6:150641400-150642200	Enhancers	Skeletal Muscle Female	skeletal muscle
36	chr6:150641400-150642200	Enhancers	Osteobl	bone
37	chr6:150641600-150641800	Enhancers	Adipose Nuclei	Adipose
38	chr6:150641600-150642000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
39	chr6:150641800-150642000	Bivalent Enhancer	Muscle Satellite Cultured Cells	--
40	chr6:150641800-150642800	Weak transcription	Adipose Nuclei	Adipose
41	chr6:150641800-150643200	Weak transcription	Fetal Muscle Trunk	muscle
42	chr6:150641800-150644400	Weak transcription	Left Ventricle	heart
43	chr6:150642000-150642200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
44	chr6:150642000-150646200	Weak transcription	Breast Myoepithelial Primary Cells	Breast
45	chr6:150642000-150648200	Weak transcription	Aorta	Aorta
46	chr6:150642000-150648400	Weak transcription	Right Ventricle	heart
47	chr6:150642200-150642600	Weak transcription	Fetal Muscle Leg	muscle
48	chr6:150642200-150642600	Weak transcription	Psoas Muscle	Psoas
49	chr6:150642200-150642600	Weak transcription	Skeletal Muscle Female	skeletal muscle
50	chr6:150642200-150643000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links